Kamil Ali-Jackson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Malvern, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Raymond Furey (Attorney-in-Fact)
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kamil Ali-Jackson

Form 4 holding Chief Legal Officer

Aclaris Therapeutics, Inc.

Security class
Common Stock
Shares / value
160,214
Estimated value
$168,225
Report date
03 Jan 2022
Price
$1.05
Ownership
Direct
Form 4 holding Director

PDS Biotechnology Corp

Security class
Employee Stock Option (Right to Buy)
Shares / value
54,876
Estimated value
Report date
12 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Legal Officer

Aclaris Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
03 Jan 2022
Price
$1.05
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kamil Ali-Jackson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .